Peripheral and total parenteral nutrition as the strongest risk factors for nosocomial candidemia in elderly patients: A matched case-control study

Mycoses

Volumn 56, Issue 6, 2013, Pages 664-671

  Luzzati, Roberto ^a   Cavinato, Silvia ^a   Giangreco, Manuela ^b   Granà, Gianluca ^a   Centonze, Sandro ^a   Deiana, Maria L ^a   Biolo, Gianni ^a   Barbone, Fabio ^b  

^a UNIVERSITY HOSPITAL OF TRIESTE   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

Author keywords

Candidemia; Elderly; Nosocomial infection; Predictive rules; Risk factors

Indexed keywords

GLYCOPEPTIDE; POLYPEPTIDE ANTIBIOTIC AGENT;

AGED; AGED HOSPITAL PATIENT; ANTIBIOTIC THERAPY; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; ARTIFICIAL VENTILATION; BLOOD CULTURE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDEMIA; CELLULITIS; DISEASE SEVERITY; ENTERIC FEEDING; FEMALE; FUNGAL COLONIZATION; HEMODIALYSIS; HOSPITAL ADMISSION; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; INTRAVASCULAR CATHETER; INVASIVE CANDIDIASIS; MAJOR CLINICAL STUDY; MAJOR SURGERY; MALE; MALIGNANT NEOPLASTIC DISEASE; NEUTROPENIA; PERIPHERAL PARENTERAL NUTRITION; PERITONITIS; PNEUMONIA; PRIORITY JOURNAL; SEPTIC SHOCK; SPECIES IDENTIFICATION; STEROID THERAPY; TOTAL PARENTERAL NUTRITION; TREATMENT DURATION; URINARY TRACT INFECTION; VERY ELDERLY;

CANDIDA ALBICANS;

CANDIDEMIA; ELDERLY; NOSOCOMIAL INFECTION; PREDICTIVE RULES; RISK FACTORS;

AGED; AGED, 80 AND OVER; CANDIDA; CANDIDEMIA; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; PARENTERAL NUTRITION, TOTAL; RISK FACTORS; TIME FACTORS;

EID: 84886242506     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/myc.12090     Document Type: Article

References (29)

1. Marchetti O, Bille J, Fluckinger U et al. Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000. Clin Infect Dis 2004; 38: 311-20.
2. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24, 179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39: 309-17.
3. Horn DL, Neofytos D, Anaissie EJ et al. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis 2009; 48: 1695-703.
4. Bassetti M, Molinari MP, Mussap M, Viscoli C, Righi E. Candidemia in internal medicine departments: the burden of a rising problem. Clin Microbiol Infect 2013; (in press) doi:10.1111/1469-0691.12155
5. Gudlaugsson O, Gillespie S, Lee K et al. Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 2003; 37: 1172-7.
6. Andes DR, Safdar N, Baddley JW et al. Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clin Infect Dis 2012; 54: 1110-22.
7. Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis 2003; 3: 685-702.
8. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microb Rev 2007; 20: 133-63.
9. Zilberberg MD, Shorr AF, Kollef MH. Secular trends in candidemia-related hospitalization in the United States, 2000-2005. Infect Control Hosp Epidemiol 2008; 29: 978-80.
10. Cleveland AA, Farley MM, Harrison LH et al. Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008-2011. Clin Infect Dis 2012; 55: 1352-61.
11. Greenland S, Thomas DC. On the need for the rare disease assumption in case-control studies. Am J Epidemiol 1982; 116: 547-53.
12. Annane D, Bellisant E, Cavaillon JM. Septic shock. Lancet 2005; 365: 63-78.
13. Zaoutis TE, Prasad PA, Localio AR et al. Risk factors and predictors for candidemia in pediatric intensive care unit patients: implication for prevention. Clin Infect Dis 2010; 51: e38-45.
14. McCabe WR, Jackson GG. Gram-negative bacteremia. Arch Int Med 1962; 110: 847-55.
15. Owens WD, Felts JA, Spitzagel EL. ASA physical status classifications: a study of consistency of rating. Anesthesiology 1978; 49: 239-43.
16. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York: John Wiley & Sons, 1989.
17. Muskett H, Shahin J, Eyres G, Harvey S, Rowan K, Harrison D. Risk factors for invasive fungal disease in critically ill adult patients: a systematic review. Crit Care 2011; 15: R287.
18. Blumberg HM, Jarvis WR, Soucie JM et al. Risk factors for candida bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. Clin Infect Dis 2001; 33: 177-86.
19. Chow JK, Golan Y, Ruthazer R et al. Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit. Clin Infect Dis 2008; 46: 1206-13.
20. Leibovitz E, Iuster-Reicher A, Amital M, Mogilner B. Systemic candidal infections associated with use of peripheral venous catheters in neonates: a 9-year experience. Clin Infect Dis 1992; 14: 485-91.
21. Branchini ML, Pfaller MA, Rhine-Chalberg J, Frempong T, Isenberg HD. Genotypic variation and slime production among blood and catheter isolates of Candida parapsilosis. J Clin Microb 1994; 32: 452-6.
22. Shin JH, Kee SJ, Shin MG et al. Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates from other sources. J Clin Microb 2002; 40: 1244-8.
23. Swindell K, Lattif AA, Chandra J, Mukherjee PK, Ghannoum MA. Parenteral lipid emulsion induces germination of Candida albicans and increases biofil formation on medical catheter surfaces. J Infect Dis 2009; 200: 473-80.
24. Pappo I, Polacheck I, Zmora O, Feigin E, Freund HR. Alterated gut barrier function to Candida during parenteral nutrition. Nutrition 1994; 10: 151-4.
25. Karabinis A, Hill C, Leclercq B, Tancrède C, Baume D, Andremont A. Risk factors for candidemia in cancer patients: a case-control study. J Clin Microb 1988; 26: 429-32.
26. Samonis G, Gikas A, Anaissie EJ et al. Prospective evaluation of effects of broad-spectrum antibiotics on gastrointestinal yeast colonization of humans. Antimicrob Agents Chemother 1993; 37: 51-53.
27. Samonis G, Galanakis E, Ntaoukakis M et al. Effects of carbapenems and their combination with amikacin on murine gut colonization by Candida albicans. Mycoses 2012; (in press) doi:10.1111/j.1439-0507.2012.02212.x
28. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Risk factors for hospital-acquired candidemia: a matched case control study. Arch Intern Med 1989; 149: 2349-53.
29. Bross J, Talbot GH, Maislin G, Hurwitz S, Strom BL. Risk factors for nosocomial candidemia: a case-control study in adults without leukemia. Am J Med 1989; 87: 614-20.